The Epidemiology of Progressive Supranuclear Palsy

Handbook of Clinical Neurology

Volumn 89, Issue , 2008, Pages 457-459

  Golbe, Lawrence I ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENETICS; HUMAN; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; RISK FACTOR;

HUMANS; RISK FACTORS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 66049148587     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)01242-0     Document Type: Review

References (12)

1. Baker K.M., and Montgomery Jr. E.B. Performance on the PD test battery by relatives of patients with progressive supranuclear palsy. Neurology 56 (2001) 25-30
2. Bower J.H., Maraganore D.M., McDonnell S.K., et al. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 49 (1997) 1284-1288
3. Caparros-Lefebvre D.E., and The Caribbean Parkinsonism Study Group. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Lancet 54 (1999) 281-286
4. Cox P.A., Banack S.A., and Murch S.J. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci USA 100 (2003) 13380-13383
5. Davis P.H., Golbe L.I., Duvoisin R.C., et al. Risk factors for progressive supranuclear palsy. Neurology 38 (1988) 1546-1552
6. Golbe L.I., Davis P.H., Schoenberg B.X., et al. Prevalence and natural history of progressive supranuclear palsy. Neurology 38 (1988) 1031-1034
7. Golbe L.I., Rubin R.S., Cody R.P., et al. Follow-up study of risk factors in progressive supranuclear palsy. Neurology 47 (1996) 148-1554
8. Litvan I., Mangone C.A., McKee A., et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 60 (1996) 615-620
9. Nath U., Ben-Shlomo Y., Thomson R.G., et al. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 124 (2001) 1438-1449
10. Nath U., Thomson R., Wood R., et al. Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neurol Neurosurg Psychiatry 76 (2005) 498-502
11. Schrag A., Ben-Shlomo Y., and Quinn N.P. Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study. Lancet 354 (1999) 1771-1775
12. Vanacore N., Bonifati V., Colosimo C., and European Study Group on A typical Parkinsonism (ESGAP). Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms. Neurol Sci 22 (2001) 101-103